Medical Science Liaison - CNS/Neurology, Rocky Mountains

SK Life Science, Inc.; Paramus (NJ); On-site; USD 160,000 - 215,000; Full time

Benefits offered by this job

401(k) with company match

Medical, dental, and vision coverage

Job summary

SK Life Science, Inc. is seeking a Medical Science Liaison for the Rocky Mountains region. This field-based role focuses on Epilepsy and CNS/Neurology, delivering cutting-edge data and education to healthcare professionals across Colorado, Arizona, Utah, and surrounding states.

You will cultivate relationships with key experts, support investigator-sponsored studies, and collaborate with clinical teams to advance the company’s CNS portfolio while adhering to regulatory guidelines.

Qualifications

• MD, Pharm D, Nurse Practitioner, PhD Degree with appropriate clinical or scientific experience.
• Industry and/or clinical experience in Epilepsy and/or CNS/Neurology highly desirable.
• Willing/able to travel 50%+ including domestic and international travel as needed.

Responsibilities

• Develop and maintain relationships with CNS experts and KOLs in Epilepsy/CNS neurology.
• Deliver non-promotional scientific information to HCPs and payers.
• Participate in medical education at meetings, advisory boards, and investigator meetings.
• Coordinate with clinical teams to support sites/investigators in clinical trials.
• Provide timely clinical information in response to unsolicited inquiries.

Skills

Communication skills

Presentation skills

Strategic thinking

Travel readiness

Education

MD/PhD/DO with clinical or scientific experience

Job description

SK Life Science, Inc. is seeking a Medical Science Liaison for the Rocky Mountains region. This field-based role focuses on Epilepsy and CNS/Neurology, delivering cutting-edge data and education to healthcare professionals across Colorado, Arizona, Utah, and surrounding states.

You will cultivate relationships with key experts, support investigator-sponsored studies, and collaborate with clinical teams to advance the company’s CNS portfolio while adhering to regulatory guidelines.